More I look at their report and presentation, the more rubbish I see. Waste of time really barely tells me anything of substance.
Very good at telling Revenue is up 10% and ebitda up 11% yet no reason given why NPAT not moved. Because depreciation is tracking in excess of 3 million for the full year...
finance cost up and tracking at well in excess of 2 million.
Last year ebitda margin was 9.2%, back down this half to 8.9%.
Let assume they have a good H2 and full year revenue is 115 million, that 59 million revenue in the 2nd half at a 9% ebitda margin that ebitda of 10.4 million a modest increase of 6% in ebitda.
10.4 less 3 million of D&A and 2 million of finance expense gives npbt of 5.4
5.4 less tax and we're looking at 3.8 million npat.
Well, that a dud full year forecast...
Obviously they haven't got to grips with the cost blow out. They probably should start by focusing on that.
- Forums
- ASX - By Stock
- AHX
- Ann: H1 FY2019 Results Presentation
AHX
apiam animal health limited
Add to My Watchlist
7.29%
!
51.5¢

Ann: H1 FY2019 Results Presentation, page-6
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
51.5¢ |
Change
0.035(7.29%) |
Mkt cap ! $94.73M |
Open | High | Low | Value | Volume |
47.0¢ | 52.0¢ | 46.5¢ | $285.9K | 582.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 181288 | 49.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
51.5¢ | 8359 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 181288 | 0.490 |
1 | 20687 | 0.450 |
2 | 75000 | 0.445 |
2 | 27932 | 0.440 |
1 | 5088 | 0.430 |
Price($) | Vol. | No. |
---|---|---|
0.515 | 8359 | 1 |
0.525 | 13553 | 1 |
0.530 | 10000 | 1 |
0.540 | 14702 | 1 |
0.570 | 150000 | 1 |
Last trade - 16.10pm 24/06/2025 (20 minute delay) ? |
Featured News
AHX (ASX) Chart |